Dermatology Times Newsletter

To view this email as a web page, click here.

You’re reading the latest on psoriasis treatments from Dermatology Times. Our mission is to provide you with clinical insights that expand your expertise and advance your practice. Connect with us on Twitter and Facebook for daily updates.

New biosimilars appear safe, effective

Based on current data, biosimilars seem to be therapeutically equivalent to their progenitors, says these experts.

Biologics make clearance a real possibility

Biologics have given patients the possibility of complete psoriasis clearance and control of their psoriatic arthritis, which were not options 20 years ago.

Consider comorbidities

View these treatment recommendations for psoriasis patients with specific comorbidities.

From our Latest Issue

The generational dermatology practice

Mechanisms driving melanoma immunotherapy

Lasers aid actinic keratoses treatment

JOB OPPORTUNITIES

CA - Integrated Dermatology

CO-Integrated Dermatology

CT - Integrated Dermatology

District of Columbia-Integrated Dermatology

MA - Integrated Dermatology

MD - Integrated Dermatology

MS - Integrated Dermatology

National - Integrated Dermatology

NJ - Integrated Dermatology

NJ - Practice for Sale

NV - Integrated Dermatology

VA - Integrated Dermatology

VT - Integrated Dermatology

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.